Brief: Viracta Therapeutics Reports Closing Of Merger With Sunesis Pharmaceuticals
24/02/2021 21:07
Feb 24 (Reuters) - Sunesis Pharmaceuticals Inc SNSS.O :
* VIRACTA THERAPEUTICS ANNOUNCES CLOSING OF MERGER WITH
SUNESIS
PHARMACEUTICALS AND $65M PRIVATE PLACEMENT
Source text for Eikon: ID:nPn4vNvLa
Further company coverage: SNSS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update